The Role of Receptor for AGEs(RAGE) on Low Turnover Bone
| Project/Area Number |
22790790
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Kidney internal medicine
|
|---|
| Research Institution | Kobe University |
|---|
Principal Investigator |
HAMADA Yasuhiro 神戸大学, 医学部附属病院, 特命講師 (30397830)
|
|---|
| Project Period (FY) |
2010 – 2011
|
| Project Status |
Completed (Fiscal Year 2011)
|
| Budget Amount *help |
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2011: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2010: ¥2,860,000 (Direct Cost: ¥2,200,000、Indirect Cost: ¥660,000)
|
|---|
| Keywords | 糖尿病 / 骨病変 / 合併症 / 糖化最終産物 / 糖化最終産物受容体 / 骨代謝 / 酸化ストレス / 低回転骨 |
|---|
| Research Abstract |
We have reported that diabetes induced low turnover bone in streptozotocin-induced diabetic mouse. It has been reported that AGEs and the receptor for AGEs(RAGE) have been linked to the pathogenesis of diabetic microangiopathy. However, the relationship between RAGE and alteration in bone metabolism is unclear. Therefore, in order to determine the role of RAGE in bone metabolism, we investigated the effects of RAGE deletion on bone metabolism under physiological and diabetic conditions using RAGE knockout mice(RAGE-KO). Eight-week-old male RAGE-KO and wild-type littermates(WT) were intraperitoneally injected with either streptozotocin or vehicle. Mice were divided into four groups : 1) nondiabetic WT ; 2) nondiabetic RAGE-KO ; 3) diabetic WT ; and 4) diabetic RAGE-KO. After 12 weeks of streptozotocin or vehicle treatment, the physical properties of femora and the static and dynamic parameters of bone histomorphometry of tibiae were assessed. The deletion of RAGE affected neither body weights nor hemoglobin A1c levels. RAGE deletion resulted in increased bone mineral density due to decreased osteoclast function under physiological conditions that is no accumulation of AGEs. In contrast, lacking RAGE did not affect the alteration in bone metabolism under diabetic conditions, suggesting that AGEs-RAGE interaction may not be involved in the pathogenesis of diabetic osteopenia, which expresses low turnover bone, although RAGE plays an important role in bone metabolism.
|
Report
(3 results)
Research Products
(9 results)
-
[Journal Article] Carvedilol ameliorates low-turnover bone disease in non-obese type 2 diabetes2011
Author(s)
Goto S, Fujii H, Kono K, Nakai K, Hamada Y, Yamato H, Shinohara M, Kitazawa R, Kitazawa S, Nishi S, Fukagawa M.
-
Journal Title
Am J Nephrol
Volume: 34(3)
Pages: 281-90
Related Report
Peer Reviewed
-
[Journal Article] The effects of the receptor for advancedglycation end products(RAGE) on bone metabolism under physiological and diabetic conditions2010
Author(s)
Hamada Y, Kitazawa S, Kitazawa R, Kono K, Goto S, Komaba H, Fujii H, Yamamoto Y, Yamamoto H, Usami M, Fukagawa M.
-
Journal Title
Endocrine
Volume: 38(3)
Pages: 369-76
Related Report
Peer Reviewed
-
-
-
-
-
[Presentation] 糖尿病と骨病変2011
Author(s)
濱田康弘
Organizer
平成23年度兵庫県糖尿病協会栄養部会
Place of Presentation
兵庫県神戸市、兵庫国際交流会館(招待講演)
Year and Date
2011-06-11
Related Report
-
-
